Table 1.
Baseline characteristics of healthy children and pediatric patients with ALL (serum samples).
| No | Sample type | Sex | Age (at ND) | Chromosome | CR duration |
|---|---|---|---|---|---|
| 1 | Healthy control | Male | 3 | None | - - |
| 2 | Healthy control | Female | 9 | None | - - |
| 3 | Healthy control | Female | 12 | None | - - |
| 4 | ND and matched CR | Male | 4 | t(12;21) | - - |
| 5 | ND and matched CR | Female | 11 | None | - - |
| 6 | ND and matched CR | Female | 8 | None | - - |
| 7 | RE | Male | 3 | t(12;21) | 23 months |
| 8 | RE | Female | 7 | None | 31 months |
| 9 | RE | Female | 12 | None | 43 months |
ALL: acute lymphoblastic leukemia; CR: complete remission; ND: new diagnosis; RE: relapse